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In May 2013, the WHO Member States requested the WHO to establish a Global Observatory on Health Research
and Development (R&D), as part of a strategic work-plan to promote innovation, build capacity, improve access,
and mobilize resources to address diseases that disproportionately affect the world’s poorest countries.
The rationale for establishing a Global Observatory on Health R&D is to provide a mechanism to monitor and
analyse health R&D resource flows, product pipelines, and research outputs, aiming to contribute to the identification
of gaps to inform priority-setting for new R&D investments to be operationalized through a new global financing and
coordination mechanism for health R&D and utilized by all stakeholders informing health research policy decisions in
countries, civil society, and the private sector.
As one of the mechanisms to achieve the goals of the Global Observatory on Health R&D, the WHO is launching a
Call for Papers to be published as a Thematic Series in Health Research Policy and Systems to contribute state-of-the-art
knowledge and innovative approaches to analyse, interpret, and report on health R&D information. Further, to serve as
a key resource to inform the future WHO-convened coordination mechanism, which will be utilized to generate
evidence-informed priorities for new R&D investments to be financed through a proposed new global financing and
coordination mechanism for health R&D.
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After almost a decade since calling for closing the 10/90
gap, a concept put forward by the Commission on Health
Research for Development to highlight disparities in
research and development support for neglected diseases
affecting the world’s poorest countries [1], the World
Health Organization (WHO) and its Member States are
now united in recognizing the urgency in addressing the
health needs of the world’s poorest countries. In particular,
the inequities in the current research landscape due to
recognized market failures and the need for increasing
investments in health research and development (R&D)
related to diseases that overwhelmingly or predominantly
affect the poor (Type III and Type II diseases), as well as
the specific R&D needs of low- and middle-income* Correspondence: adamt@who.int
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Related to this, in May 2013, the World Health
Assembly, in its resolution 22.66, requested the WHO to
establish a Global Observatory on Health R&D, as part
of a strategic work-plan along with other actions includ-
ing exploring the possibilities for the development of a
global financing and coordination mechanism for health
R&D to promote innovation, build capacity, improve
access, and mobilize resources to address diseases that
disproportionately affect the world’s poorest countries
[3]. The ultimate goal is the development and delivery of
affordable, effective, safe, and quality health products,
especially those for which existing market mechanisms
fail to provide incentives for R&D.
The rationale for establishing a Global Observatory
on Health R&D is to provide a mechanism to monitor
and analyse relevant existing information on health
R&D, including resource flows, product pipelines, andioMed Central. This is an open access article distributed under the terms of the
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identification of gaps and opportunities for health R&D
and to inform priority-setting for new R&D invest-
ments based on the public health needs of the world’s
poorest countries.
Seizing the opportunity for health research and
development: introducing a new journal series
To take advantage of this momentum and recognizing the
pressing need for high quality evidence on the availability
of and gaps in health R&D to inform future allocation of
resources [4], the WHO is issuing a Call for Papers invit-
ing interested researchers and institutions to contribute to
the knowledge base necessary to inform these decisions,
taking advantage of the data made available through the
Global Observatory platform and the associated resources
on the dedicated WHO website.
The overall goal of this Call is the publication of a
selection of papers to contribute to a new peer-reviewed
journal Series on “Health R&D”. With such a timely
collection of articles and cutting-edge knowledge in this
field, the WHO aims to provide global stakeholders with
up-to-date knowledge on methods, strategies, tools,
experiences, and applications to draw from when devel-
oping future investment decisions and implementation
plans for new R&D. More importantly, the aim is to
push the frontier for knowledge and innovation in this
field by inviting new thinking, approaches, analysis, and
information, and welcome a wide range of perspectives
and disciplines relevant to understanding the availability
of and funding for health R&D.
Scope of the series and the Call for Papers
We welcome primary research in the categories and topics
described below. Articles providing new knowledge and
innovative techniques will be prioritized as well as analysis
of diseases that overwhelmingly or predominantly affect
the poor, e.g., neglected diseases. Purely descriptive articles
or those that simply seek to argue for the importance of
investments on health R&D or make the case for why it
matters are not encouraged in the context of this Series.
The examples below are to provide some ideas of what
would be considered relevant for this Call. Nevertheless,
other ideas that fit the purpose and scope of this Call are
also welcome.
Methodologies
This category of papers may include methodological de-
velopments, approaches, tools, or explorations to sup-
port analysis or understanding of the range of health
R&D and related investments, as well as approaches to
incorporate the associated learning in the policy making
process. This could be a reflection of existing experi-
ences as well as exploration of new ideas.Some examples of methodological topic areas include:
1. Priority setting for health R&D – methodologies for
defining needs (including evidence on burden of
disease, evidence on severity of disease, product
gaps, demand/market size projections, stakeholder
values, etc.)
2. Decision making for funding R&D/methods for
selecting new R&D (including technical- and
process-related tools, e.g., to determine trade-offs
between alternatives, including elements such as
market incentives and failures, etc.)
3. Handling financial flow data with a focus on R&D
4. Measuring expenditure data with a focus on R&D
5. Assessing product pipelines (e.g., in terms of quality,
sustainability, and relevance to needs and/or priorities)
6. Approaches to assessing research outputs
(e.g., bibliometrics or social network analyses)
7. Approaches to assessing research results (e.g., in
terms of the range of products and innovation)
8. Forecasting future R&D funding needs
9. Forecasting future R&D funding levels
Reviews
Reviews of empirical work that discuss or clarify the
different approaches to explore the availability, ethics,
capacity for, and investments in health R&D. These may
include:
1. Reviews of ethical considerations in developing new
R&D for particular population groups, diseases, or
product types
2. Resource tracking tool assessments for R&D, for
example, for:
a) Product pipelines: i) product developers and what
they develop; ii) evaluating tracking tools and
their strengths and limitations
b) R&D funding: i) funders and what they fund; ii)
evaluating tracking tools and their strengths and
limitationsAnalyses
This category may include analytical work to inform
future research or new investment decisions on health
R&D, for example:
1. Funding trends and R&D gap analyses by disease
area/product area/R&D stage
2. Landscape analyses of financing mechanisms for
incentivizing R&D
3. Landscape analyses of platforms for implementing
R&D (competitive vs. collaborative models)
4. In-depth product development pipeline analyses by
disease area/product area/R&D stage
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by disease area/product area/R&D stage (his could
be tailored, for example, by looking at Product
Development Partnership expenditures first)
6. Bottleneck analyses in R&D (translational,
manufacturing, intellectual property, regulatory, etc.)
7. Survey-based analyses of stakeholder motivations
behind funding and selecting R&D
8. Predictive analyses of expected future R&D funding
and barriers/success factors to meeting funding needs
9. Bibliometric analysis of research outputs, for
example, covering:
a. What topics, studies, to what extent, by whom
b. Research collaborators and their networks
Utilization
This category may, for example, make use of case studies
to share innovative ideas or experiences that have
worked in the health R&D field. These may include:
1. Case studies of best-practice models of financing or
managing R&D
2. Cases where rigorous monitoring and analyses have
been utilized to inform decision making
How to apply to the call for papers
Interested researchers are invited to submit an abstract
to adamt@who.int using the guidelines and template
available in Additional file 1 and on the WHO website
http://www.who.int/healthsystems/r-d_observatory. The
deadline for submission is the 8th of March, 2015
(23:59 GMT). An external scientific committee will
select abstracts for potential inclusion in the Series.
The final decision for inclusion rests with the editors of
Health Research Policy and Systems, following the usual
peer-review process. The Series aims to cover up to 25
articles of diverse nature and topics. If the desired
number and diversity of articles is not reached, the
deadline for accepting abstracts for this Call will be
extended and will be announced on the WHO website
(link above). Selection of additional papers after the
deadline will follow the same process.
Looking forward
There are several needs and opportunities for methodo-
logical developments and new information to support
analysis and priority setting for health R&D. With this
new Thematic Series on health R&D, we hope to encour-
age researchers and institutions interested in this field to
address or advance some of them. The ultimate goal is to
inform the establishment of the WHO’s Global Observa-
tory on Health R&D and to guide future decision-making
and priority setting in this area.Global stakeholders have various roles to play to take
advantage of the momentum created by the World Health
Assembly’s Resolution and the powerful underlying desire
to redress the current imbalances in health R&D invest
ments, particularly WHO Member States’ request to the
WHO to explore the possibilities for hosting a pooled
fund, which would finance priority R&D projects. The
priorities of the fund would be informed by the analysis of
the research landscape provided by the Global Observa-
tory on Health R&D, including those provided by this
Thematic Series, as recommended by the future WHO-
convened coordination mechanism [3].
We, therefore, believe that this Series is well positioned
to provide timely, high quality, easily accessible, and rele-
vant information to capitalize on this momentum and,
more importantly, to serve as a key resource to inform
this global agenda with the ultimate goal to address prior-
ity research gaps for health R&D that disproportionately
affect the world’s poorest countries.
Additional file
Additional file 1: Guidelines for submission of abstracts.
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